首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1391906

白血病筛检市场：依测试类型、依疾病类型、依年龄层、依最终使用者、按地区

Leukemia Screening Market, By Test Type, By Disease Type, By Age Group, By End User, By Geography

出版日期: 2023年11月08日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

据估计，2023 年全球白血病筛检市场规模将达到 72.8 亿美元，预计到 2030 年将达到 116.6 亿美元，预测期内年复合成长率(CAGR)为 7%。

报告范围		报告详情
基准年	2022年	2023年市场规模	72.8亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	7.00%	2030年市场规模预测	116.6亿美元

图 1. 2023 年按地区分類的白血病筛检全球市场占有率(%)

白血病是一种影响血球的癌症。白血病是一种严重的疾病，导致许多人死亡，对家庭和医疗保健系统带来沉重负担。白血病的主要诊断工具是实验室检查和身体检查。全血球计数 (CBC) 检查体内红血球、白血球和血小板的水平。如果您的异常白血球数量较多，您可能患有白血病。某些类型的白血病细胞在血液中循环，而另一些则保留在骨髓中并且不会出现在常规血液检查中。由于全球各类白血病发病率不断上升，全球白血病筛检市场在过去几年中出现了显着成长。白血病是一种始于骨髓的血癌，由异常白血球引起。由于环境污染加剧、生活习惯改变以及世界人口高龄化，白血病患者数量不断增加。因此，开发中国家对早期发现白血病的先进筛检测试的需求都在增加。旨在提高人们对白血病的认识和提供创新筛检解决方案的各种公共和私人倡议正在进一步推动全球白血病筛检产业的发展。

本研究的主要特点

本报告详细分析了全球白血病筛检市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球白血病筛检市场的主要企业。
该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
全球白血病筛检市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球白血病筛检市场的各种策略矩阵来促进决策。

北美洲
美国
加拿大
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
其他欧洲国家
亚太地区
中国
印度
日本
澳洲
韩国
ASEAN
其他亚太地区
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
南非
中部非洲
北非

第10章竞争形势

公司简介
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN NV
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.

第11章章节

参考
调查方法
关于出版商

简介目录

Product Code: CMI5859

Global leukemia screening market is estimated to be valued at US$ 7.28 Bn in 2023 and is expected to reach US$ 11.66 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.28 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.00%	2030 Value Projection:	US$ 11.66 Bn

Figure 1. Global Leukemia Screening Market Share (%), By Region, 2023

Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.

Market Dynamics:

The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled "Community-Acquired Pneumonia", the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.

Key features of the study:

This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market

Detailed Segmentation:

Global Leukemia Screening Market, By Test Type
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Polymerase Chain Reaction (PCR)
- Immunophenotyping
- Others
Global Leukemia Screening Market, By Disease Type
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Others
By Age Group
- Pediatric
- Adult
- Geriatric
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
By Region
- North America
- Europe
- Latin America
- Middle East
- Africa
Top Companies in the Global Leukemia Screening Market:
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing incidence of leukemia
- High cost of screening procedures
- Expansion in emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Leukemia Screening Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Leukemia Screening Market, By Test Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Complete Blood Count (CBC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Bone Marrow Aspiration and Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cytogenetic Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Immunophenotyping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Leukemia Screening Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Chronic Lymphocytic Leukemia (CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Chronic Myeloid Leukemia (CML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

7. Global Leukemia Screening Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )

8. Global Leukemia Screening Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn )
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Leukemia Screening Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
South Africa
Central Africa
North Africa